Gaps of the COVID-19 Vaccination Program in Selected Sites in Mindanao, Philippines

Reneepearl Kim Sales; Lynnell Alexie Ong; Joseph Aaron Joe; Kristine Alvina; Michael Caampued

doi:10.1177/10105395221083386

Gaps of the COVID-19 Vaccination Program in Selected Sites in Mindanao, Philippines

Reneepearl Kim Sales^*, Lynnell Alexie Ong, Joseph Aaron Joe, Kristine Alvina, Michael Caampued

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)

Abstract

Access to health products in low- and middle-income countries (LMICs) continues to be a challenge.1 Despite availability, challenges in affordability, allocation, and deployment pose hurdles in ensuring equitable global access to COVID-19 vaccines.2 Following the receipt of 600,000 Sinovac vaccines, the Philippines began its vaccine rollout on 1 March 2021.3 As of 11 January 2022, only 48.45% of the country’s population are fully vaccinated.4 For a vaccine program to be successful, it is crucial to invest not just in vaccines but in the program as a whole. This study aimed to identify main COVID-19 vaccine implementation gaps across four study sites in Mindanao, Philippines under The Asia Foundation’s CONVERGE program (Radjah Buayan, Maguindanao; Maluso, Basilan; Tungawan, Zamboanga Sibugay; Zamboanga City) by interviewing health officers, healthcare workers (HCWs), and community representatives.

Original language	English
Pages (from-to)	576-579
Number of pages	4
Journal	Asia Pacific Journal of Public Health
Volume	34
Issue number	5
DOIs	https://doi.org/10.1177/10105395221083386
Publication status	Published - Jul 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/10105395221083386

Cite this

@article{e1fb0728f9984f408db18a4bee0bc4c7,

title = "Gaps of the COVID-19 Vaccination Program in Selected Sites in Mindanao, Philippines",

abstract = "Access to health products in low- and middle-income countries (LMICs) continues to be a challenge.1 Despite availability, challenges in affordability, allocation, and deployment pose hurdles in ensuring equitable global access to COVID-19 vaccines.2 Following the receipt of 600,000 Sinovac vaccines, the Philippines began its vaccine rollout on 1 March 2021.3 As of 11 January 2022, only 48.45% of the country{\textquoteright}s population are fully vaccinated.4 For a vaccine program to be successful, it is crucial to invest not just in vaccines but in the program as a whole. This study aimed to identify main COVID-19 vaccine implementation gaps across four study sites in Mindanao, Philippines under The Asia Foundation{\textquoteright}s CONVERGE program (Radjah Buayan, Maguindanao; Maluso, Basilan; Tungawan, Zamboanga Sibugay; Zamboanga City) by interviewing health officers, healthcare workers (HCWs), and community representatives.",

author = "Sales, {Reneepearl Kim} and Ong, {Lynnell Alexie} and Joe, {Joseph Aaron} and Kristine Alvina and Michael Caampued",

year = "2022",

month = jul,

doi = "10.1177/10105395221083386",

language = "English",

volume = "34",

pages = "576--579",

journal = "Asia Pacific Journal of Public Health",

number = "5",

}

TY - JOUR

T1 - Gaps of the COVID-19 Vaccination Program in Selected Sites in Mindanao, Philippines

AU - Sales, Reneepearl Kim

AU - Ong, Lynnell Alexie

AU - Joe, Joseph Aaron

AU - Alvina, Kristine

AU - Caampued, Michael

PY - 2022/7

Y1 - 2022/7

N2 - Access to health products in low- and middle-income countries (LMICs) continues to be a challenge.1 Despite availability, challenges in affordability, allocation, and deployment pose hurdles in ensuring equitable global access to COVID-19 vaccines.2 Following the receipt of 600,000 Sinovac vaccines, the Philippines began its vaccine rollout on 1 March 2021.3 As of 11 January 2022, only 48.45% of the country’s population are fully vaccinated.4 For a vaccine program to be successful, it is crucial to invest not just in vaccines but in the program as a whole. This study aimed to identify main COVID-19 vaccine implementation gaps across four study sites in Mindanao, Philippines under The Asia Foundation’s CONVERGE program (Radjah Buayan, Maguindanao; Maluso, Basilan; Tungawan, Zamboanga Sibugay; Zamboanga City) by interviewing health officers, healthcare workers (HCWs), and community representatives.

AB - Access to health products in low- and middle-income countries (LMICs) continues to be a challenge.1 Despite availability, challenges in affordability, allocation, and deployment pose hurdles in ensuring equitable global access to COVID-19 vaccines.2 Following the receipt of 600,000 Sinovac vaccines, the Philippines began its vaccine rollout on 1 March 2021.3 As of 11 January 2022, only 48.45% of the country’s population are fully vaccinated.4 For a vaccine program to be successful, it is crucial to invest not just in vaccines but in the program as a whole. This study aimed to identify main COVID-19 vaccine implementation gaps across four study sites in Mindanao, Philippines under The Asia Foundation’s CONVERGE program (Radjah Buayan, Maguindanao; Maluso, Basilan; Tungawan, Zamboanga Sibugay; Zamboanga City) by interviewing health officers, healthcare workers (HCWs), and community representatives.

UR - http://www.scopus.com/inward/record.url?scp=85126041813&partnerID=8YFLogxK

U2 - 10.1177/10105395221083386

DO - 10.1177/10105395221083386

M3 - Article

VL - 34

SP - 576

EP - 579

JO - Asia Pacific Journal of Public Health

JF - Asia Pacific Journal of Public Health

IS - 5

ER -

Gaps of the COVID-19 Vaccination Program in Selected Sites in Mindanao, Philippines

Abstract

UN SDGs

Access to Document

Other files and links

Cite this